Skip to content

CorMedix CRMD Convertible Preferred Stock Issued Shares

Convertible Preferred Stock Issued Shares at other companies

Emergent Biosolutions logo
Emergent BiosolutionsEBS
0
ICU Medical logo
ICU MedicalICUI
0
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
0
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
0
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
0
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesIssued.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's convertible preferred stock issued shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's convertible preferred stock issued shares?
CorMedix (CRMD) reported convertible preferred stock issued shares of 91.6K in Q1 2026.
How has CorMedix's convertible preferred stock issued shares changed year-over-year?
CorMedix's convertible preferred stock issued shares decreased by 0.0% year-over-year, from 91.6K to 91.6K.
What is the long-term trend for CorMedix's convertible preferred stock issued shares?
Over 5 years (2020 to 2025), CorMedix's convertible preferred stock issued shares has grown at a -17.6% compound annual growth rate (CAGR), from 241.6K to 91.6K.
What does convertible preferred stock issued shares mean?
Number of convertible preferred shares that have been issued, whether held by investors or in treasury.